Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Gynecol Oncol. 2019 Jul 21;154(3):516–523. doi: 10.1016/j.ygyno.2019.07.012

Figure 4. Molecular subtyping of endometrioid ovarian cancers.

Figure 4.

(A) Surrogate classifier employed for the molecular subtyping of endometrioid epithelial ovarian cancers (EOCs), based on the molecular subtypes described for endometrial cancers by The Cancer Genome Atlas [8,26]. (B), Molecular subtype distribution in EOCs from this study (left) and in endometrioid ovarian cancers from TCGA (right) [8]. (C) Kaplan-Meier progression-free survival curve for EOC patients stratified according to the endometrial cancer molecular subtypes defined with a surrogate model. Two cases (one of POLE subtype and one of CN-high (serous-like) subtype) were excluded due to limited/ lack of follow-up information. P-values of the log-rank test are shown. CN, copy-number.